Immunotherapy Response Features Identified in Pancreatic Cancer Microenvironment
Researchers compared tumor microenvironment features in pancreatic ductal adenocarcinoma cases receiving an allogeneic vaccine with or without anti-PD-1 treatment.
Evaxion Biotech Adopts Personalis Immune Profiling Platform for Melanoma Immunotherapy Trial
The companies will use Personalis' ImmunoID Next technology to analyze patient response to a combination of Evaxion's EVX-01 with the immunotherapy Keytruda.
BostonGene Collaborates With Transgene, NEC Corporation on Trials of Bespoke Cancer Vaccine
The firm will conduct genomic and transcriptomic analysis to identify predictors of response to the personalized immunotherapy TG4050.
Gallbladder Cancer Vaccine Candidate Identified Through Genomic Analysis
Researchers from MedGenome, Genentech, and multiple international institutions found potentially actionable alterations in more than 200 gallbladder cancer samples.
BD Receives FDA Supplemental Premarket Approval for Extended Genotyping HPV MDx
The expanded test can be used for genotype risk-based patient monitoring to prevent over-treatment, BD has said.